Rivastigmine - CISMeF

Preferred Label : Rivastigmine;

MeSH definition : A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.;

MeSH synonym : (S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate;

DeCS synonym : ENA 713;

MeSH hyponym : Exelon; RivastigmineTartrate; Rivastigmine Hydrogen Tartrate; Hydrogen Tartrate, Rivastigmine; Tartrate, Rivastigmine Hydrogen;

Related MeSH term : 713, ENA; SDZ ENA 713; 713, SDZ ENA; ENA 713, SDZ; ENA-713; ENA713;

MeSH CAS label : Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1);

MeSH Related Number : 123441-03-2 (rivastigmine); 129101-54-8 (rivastigmine hydrogen tartrate); 9IY2357JPE;

Wikipedia link : https://en.wikipedia.org/wiki/Exelon;

Related CISMeF synonym : ENA 713;

Is substance : O;

UNII : PKI06M3IW0;

Details

Origin ID

D000068836;

UMLS CUI

C0649350;

ATC code(s)
- rivastigmine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Pharmacological action(s)
- cholinesterase inhibitors [MeSH Descriptor]
- neuroprotective agents [MeSH Descriptor]
Record concept(s)
- ENA 713 [MeSH concept]
- Exelon [MeSH concept]
- RivastigmineTartrate [MeSH concept]
- rivastigmine [MeSH concept]
See also inter- (CISMeF)
- Product containing rivastigmine (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing rivastigmine (medicinal product) [SNOMED CT concept]
- Rivastigmine [NCIt concept]
- Rivastigmine (substance) [SNOMED CT concept]
- rivastigmine [ATC Code]
- rivastigmine [Substance BNPC]
Validated automatic mappings to BTNT
- Rivastigmine Tartrate [NCIt concept]
- Rivastigmine hydrogen tartrate [SMS substance]
- Rivastigmine tartrate (substance) [SNOMED CT concept]
- rivastigmine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients